7620 Federal Register / Vol. 80, No. 28 / Wednesday, February 11, 2015 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent and instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Total annual 

burden hours 

Adults—Biospecimen Collection: Blood .......................................... 869 1 18/60 261 

Adults—Tobacco Use Form ............................................................ 14,572 1 4/60 971 

Adults—Follow-up/Tracking Participant Information Form .............. 27,430 2 8/60 7,315 

Youth—Youth respondents at Wave 1 or Wave 2—Extended 

Interview ....................................................................................... 9,515 1 32/60 5,075 

Youth—Shadow youth who age up to youth cohort at Wave 3— 

Assent for Extended Interview ..................................................... 2,420 1 3/60 121 

Youth—Shadow youth who age up to youth cohort at Wave 3— 

Extended Interview ....................................................................... 1,912 1 42/60 1,338 

Adult—Youth respondents at Wave 1 or Wave 2—Parent Interview .............................................................................................. 9,705 1 14/60 2,265 

Adults—Parents of Shadow youth who age up to youth cohort at 

Wave 3—Parent Permission and Consent for Parent Interview 2,420 1 5/60 202 

Adults—Parents of Shadow youth who age up to youth cohort at 

Wave 3—Parent Interview ........................................................... 1,950 1 17/60 553 

Adults—Verification Interview .......................................................... 35,564 1 2/60 1,185 

Adults—Validation Interview ............................................................ 3,613 1 4/60 241 

Adults—Follow-up/Tracking Participant Information Form for 

Youth (completed by parents) ...................................................... 11,427 2 8/60 3,047 

Adults—Follow-up/Tracking Participant Information Form for sample Shadow youth (completed by parents) .................................. 2,401 2 8/60 640 

Dated: February 5, 2015. 

Genevieve deAlmeida-Morris, 

Project Clearance Liaison, National Institute 

on Drug Abuse, NIH. 

[FR Doc. 2015–02832 Filed 2–10–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; NIAMS 

Clinical Study Applications. 

Date: March 20, 2015. 

Time: 8:00 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health, One 

Democracy Plaza, Suite 800, 6701 Democracy 

Boulevard, Bethesda, MD 20892. 

Contact Person: Kan Ma, Ph.D., Scientific 

Review Officer, Scientific Review Branch 

National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, NIH, 

6701 Democracy Boulevard, Suite 814, 

Bethesda, MD 20892, 301–451–4838 mak2@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: February 5, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–02758 Filed 2–10–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel, March 16, 

2015, 08:00 a.m. to March 17, 2015, 

06:00 p.m., Bethesda North Marriott 

Hotel & Conference Center, Montgomery 

County Conference Center Facility, 5701 

Marinelli Road, North Bethesda, MD 

20852 which was published in the 

Federal Register on January 23, 2015, 

80FRN3613. 

The meeting has been changed to a 

teleconference meeting. The date and 

time remain the same. The meeting is 

closed to the public. 

Dated: February 5, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–02757 Filed 2–10–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Microbiology and Infectious Diseases 

B Subcommittee. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 28 / Wednesday, February 11, 2015 / Notices 7621 

Date: March 2–3, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Ellen S. Buczko, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 5601 

Fishers Lane, Rockville, 20892, 240–669– 

5028, ebuczko1@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 4, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–02754 Filed 2–10–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group, 

Biostatistical Methods and Research Design 

Study Section. 

Date: February 27, 2015. 

Time: 11:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Fairmont Hotel San Francisco, 950 

Mason Street, San Francisco, CA 94108. 

Contact Person: Wenchi Liang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, 301–435– 

0681, liangw3@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR–13– 

080: Accelerating the Pace of Drug Abuse 

Research Using Existing Data. 

Date: March 2, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Suzanne Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics in 

Microbiology. 

Date: March 3, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Fouad A El-Zaatari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1149, elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Radiation 

Therapy and Biology SBIR/STTR. 

Date: March 5–6, 2015. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Bo Hong, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6194, MSC 7804, Bethesda, MD 

20892, 301–996–6208, hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Language and Communication. 

Date: March 6, 2015. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Biao Tian, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3089B, MSC 7848, Bethesda, 

MD 20892, (301) 402–4411, tianbi@

csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, 

Behavioral and Social Consequences of HIV/ 

AIDS Study Section. 

Date: March 9–10, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave. NW., Washington, DC 20037. 

Contact Person: Mark P. Rubert, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–806– 

6596, rubertm@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, 

Behavioral and Social Science Approaches to 

Preventing HIV/AIDS Study Section. 

Date: March 12–13, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Nikko Hotel, 222 Mason St., San 

Francisco, CA 94102. 

Contact Person: Jose H Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 5, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–02756 Filed 2–10–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group Diabetes, 

Endocrinology and Metabolic Diseases B 

Subcommittee. 

Date: March 3–4, 2015. 


tkelley on DSK3SPTVN1PROD with NOTICES